NCT03439267View on ClinicalTrials.gov

Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events

NAActive, not recruitingINTERVENTIONAL
Enrollment

5,765

Participants

Timeline

Start Date

March 26, 2018

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Cardiovascular Primary Prevention Strategy
Interventions
COMBINATION_PRODUCT

Coronary Artery Calcium Screening and Statin Treatment

Will undergo coronary artery calcium screening and will receive statin treatment based on the cardiovascular risk algorithm.

OTHER

Standard Treatment

Patients will be managed following the AHA/ACC guidelines for statin initiation and follow-up.

Trial Locations (1)

84143

Intermountain Medical Center and Intermountain Clinics, Murray

All Listed Sponsors
lead

Intermountain Health Care, Inc.

OTHER

NCT03439267 - Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events | Biotech Hunter | Biotech Hunter